Proguanil when used in combination with chloroquine when intended specifically for malaria prophylaxis.
(S4)
Propentofylline, when intended for veterinary use. (S4)
Propylhexedrine, when used as a vasoconstrictor and decongestant in nose preparations and inhalants.
(S4)
Proteolytic (fibrinolytic) enzymes for oral use and when intended for application to the skin, unless listed
in another Schedule, and except when intended for soft contact lens cleaners and except when intended
for injection (S0, S4)
Pyrantel pamoate, including veterinary use, except when intended and registered as an anthelmintic in
terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act,
1947.
Pyridoxilate.
Sertaconazole, when intended for application to the skin. (S4)
Sodium fluoride; preparations and mixtures thereof containing 40 milligrams or more per daily dose. (S4)
Terbinafine, when intended for application to the skin. (S4)
Tetrahydrozoline, when intended for nasal use.
Thiabendazole, when intended for application to the skin. (S4)
Thiram, except when intended and registered as a fungicide in terms of the provisions of the Fertilizers,
Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947.
Ticlatone, when intended for application to the skin.
Tioconazole, when intended for application to the skin and when intended for human vaginal use,
specifically for the treatment of recurrent vaginal candidiasis. (S4)
Tolmetin, when intended for application to the skin. (S3)
L-tryptophan when intended for medicinal use as supplementation for nutritional purposes. (S5)
Xylometazoline, when intended for nasal use.
Zinc salts, preparations thereof for injection, when intended for veterinary use. (S3)
Schedule 2
[Schedule 2 added by s. 36 of Act No. 65 of 1974, substituted by Government Notices No. R.420 of 7
March, 1975, No. R.2244 of 28 November, 1975, No. R.575 of 2 April, 1976 and No. R.2082 of 5
November, 1976, amended by Government Notices No. R.278 of 25 February, 1977, No. R.437 of 1
April, 1977, No. R.1988 of 30 September, 1977, No. R.1674 of 18 August, 1978 (as amended by
Government Notice No. R.2410 of 8 December, 1978), No. R.1926 of 31 August, 1979, No. R.2507 of 9
November, 1979, No. R.2416 of 12 November, 1982, No. R.1289 of 14 June, 1985 (as amended by
Government Notice No. 155 of 31 January, 1986) and No. 154 of 31 January, 1986, substituted by
Government Notice No. 225 of 17 February, 1989, amended by Government Notices No. R.1132 of 2
June, 1989, No. R.1862 of 10 August, 1990, No. R.2841 of 7 December, 1990, No. R.2169 of
6 September, 1991, No. R.141 of 5 February, 1993 and No. R.775 of 7 May 1993, repealed, and
subsequently re-inserted (after amendment), by s. 21 of Act No. 94 of 1991, amended by Government
Notices Nos. R.1556 and R.1557 of 16 September, 1994, by Government Notice No. R.673 of 12 May,
1995, by Government Notice No. R.1496 of 13 September 1996, by Government Notice No. R.1203 of
15 October, 1999 and by Government Notice No. R.1077 of 3 November, 2000, repealed by s. 27 of Act
No. 90 of 1997 and inserted by Government Notice No. R509 in Government Gazette 24727 of 20 April,
2003 with effect from 2 May, 2003.]
Wording of Sections
(a)
All substances referred to in this Schedule are excluded when specifically packed,
labelled and used for—
(i)
Industrial purposes including the manufacture or compounding of consumer items or
products, which have no pharmacological action or medicinal purpose; and
(ii)
Analytical laboratory purposes.
(b)
All substances referred to in this Schedule include the following:
(i)
The salts and esters of such substances, where the existence of such salts and esters
is possible; and
(ii)
All preparations and mixtures of such substances where such preparations and
mixtures are not expressly excluded.
(c)
In terms of Section 22A (5) ( f ) of the Act, a practitioner, nurse or a person registered
under the Health Professions Act, 1974, other than a medical practitioner or dentist, may prescribe and
supply to patients under their care, the Schedule 2 substances and medicines provided for in the
Annexures, only within their scope of practice and subject to the conditions determined by the Medicines
Control Council. The conditions and the Annexures will be published in the Government Gazette.
Acetylcysteine.
Acetyldihydrocodeine; preparations and mixtures when compounded with one or more therapeutically
active substances and containing 20 milligrams or less of acetyldihydrocodiene (calculated as base) per
dosage unit and liquid oral preparations and mixtures containing 20 milligrams or less of
acetyldihydrocodeine (calculated as base) per 5 millilitre dosage unit. (S6)
Aconite alkaloids; substances, preparations and mixtures containing 0,02 percent or more thereof.